Search

Your search keyword '"Roussel M"' showing total 533 results

Search Constraints

Start Over You searched for: Author "Roussel M" Remove constraint Author: "Roussel M" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
533 results on '"Roussel M"'

Search Results

1. PME-PMI : quel accès à l'information ? Small- and Medium-Sized Firms and Industries: What Access to Information?

2. P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL

4. B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORK

5. Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

8. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

11. Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

13. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL

14. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts

19. Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study

20. Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic

22. Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

28. Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

29. Identification of symbol digit modality test score extremes in Huntington's disease

32. Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups

34. A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: Analysis of the FIRST trial

35. Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

39. S145 PHASE 3 RANDOMIZED STUDY OF DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D-VTD) VERSUS VTD IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PART 1 CASSIOPEIA RESULTS

40. PF603 FASTER & SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PTS TREATED WITH DARATUMUMAB, LENALIDOMIDE & DEXAMETHASONE (D-RD) VS RD: MAIA

41. PS1377 IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA TRANSPLANT-ELIGIBLE PATIENTS TREATED WITH DARATUMUMAB, BORTEZOMIB, THALIDOMIDE, AND DEXAMETHASONE: CASSIOPEIA STUDY

42. PF373 IMPACT OF ATM ALTERATIONS ON CHRONIC LYMPHOCYTIC LEUKEMIA IN GENERAL PRACTICE IN THE AREA OF NEXT GENERATION SEQUENCING

43. Erratum: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

45. Suicidal ideation in a European Huntington's disease population

47. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.

48. Identifying Psychosocial Determinants of the Development of Passion among Elite Level Hockey Players

49. Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma

50. CORRELATION BETWEEN PRE-TREATMENT LEVEL OF SOLUBLE PD-L1 AND OUTCOME IN CLASSICAL HODGKIN LYMPHOMA INCLUDED IN A PROSPECTIVE STUDY OF THE LYMPHOMA STUDY ASSOCIATION

Catalog

Books, media, physical & digital resources